CVS to Pay $315 Million to Settle Illegal Opioid Prescription Claims
CVS Health has agreed to pay $315 million to settle federal allegations that its pharmacies knowingly filled illegal prescriptions for opioids and other controlled substances for more than a decade.
The Justice Department announced the settlement Tuesday. It resolves a lawsuit the government filed in December 2024 accusing the pharmacy giant of violating the Controlled Substances Act and the False Claims Act, Fierce Healthcare reported.
What the Government Alleged
According to the Justice Department, CVS pharmacies filled controlled substance prescriptions that lacked a legitimate medical purpose or fell outside the usual course of professional practice. The alleged conduct took place from October 2013 through December 2025.
The government said those prescriptions included "dangerous and excessive" amounts of opioids and refills that were filled too early. It also pointed to so-called "trinity" prescriptions, a risky combination of an opioid, a benzodiazepine and a muscle relaxant.
Prosecutors also accused CVS of filling prescriptions written by "pill mill" prescribers, who issued large numbers of prescriptions without a legitimate medical reason, and of ignoring "red flags" that suggested prescriptions were likely illegitimate. Many of those prescriptions were billed to Medicare and other federal health care programs, according to Fox Business.
The scale was massive. According to the lawsuit, CVS sold 12 billion doses of opioids in the U.S. between 2015 and 2020, and federal health care programs paid for many of them, Forbes reported.
The government claimed the problems were driven by corporate decisions on staffing, incentive pay and performance metrics that "prioritized corporate profits over patient safety."
New Safeguards at the Pharmacy Counter
As part of the deal, CVS reached a separate agreement with the Drug Enforcement Administration that requires additional safeguards. The company must set up a hotline where employees and members of the public can report suspected illegal dispensing.
CVS must also proactively monitor dispensing patterns at its pharmacies and put procedures in place to evaluate prescribers suspected of illegal prescribing. Those steps are meant to help pharmacists spot problem prescriptions before they are filled, rather than after the drugs have already left the counter.
Associate Attorney General Stanley E. Woodward Jr. called the settlement "a significant milestone in the Justice Department's efforts to combat the opioid epidemic." "Not only does this settlement hold bad actors accountable for their fraudulent activities," Woodward said, adding, "Americans are safer because of it."
CVS Pushes Back
CVS did not admit wrongdoing as part of the settlement. The company said it "strongly disagrees with the allegations" and has "implemented best-in-class and first-of-their-kind programs" to help pharmacists make decisions for their patients.
"Our more than 27,000 CVS pharmacists do their part to help keep America healthy," the company said in a statement to Reuters, adding that its pharmacists are "highly trained in the safe and appropriate use of all medications."
CVS said it is "pleased to move forward and put this litigation behind us."
Not CVS's First Settlement
This is not the first time CVS has paid to resolve opioid claims. In 2022, the company agreed to pay nearly $5 billion to settle thousands of opioid-related lawsuits brought by state, local and Native American tribal governments. That agreement was separate from the federal case resolved this week.
The company has faced other legal battles recently as well. Last month, CVS agreed to a $20.5 million settlement over allegations that it shared customer data from its website and app with third parties.
The opioid crisis continues to evolve, with health officials now warning about a new opioid that may be even stronger than fentanyl. The Justice Department has described the CVS settlement as part of a broader effort to crack down on pharmacies that unlawfully fill controlled substance prescriptions.
Curious for more stories that keep you informed and entertained? From the latest headlines to everyday insights, YourLifeBuzz has more to explore. Dive into what’s next.